NCT02541084View on ClinicalTrials.gov

Caregiver Burden of Wet Age-related Macular Degeneration (wAMD) in Japan

CompletedOBSERVATIONAL

Enrollment

72

Participants

Timeline

Start Date

August 18, 2015

Primary Completion Date

March 30, 2016

Study Completion Date

July 30, 2016

Conditions

Wet Macular Degeneration

Interventions

DRUG

Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

Anti-VEGF therapy following the Summary of Product Characteristics

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Bayer

INDUSTRY